Volume 40 Issue 9, September 2022

Despite its checkered reputation, cryptocurrency is being considered by a handful of academics as a means to funnel funds into translational research. Is the trend likely to spread? Laura DeFrancesco and Ariel Klevecz investigate.

Manufacturers of brand-name nebulizer solutions have employed a variety of strategies to preserve market dominance over their products but have been less successful than manufacturers of brand-name inhalers in preventing generic competition.

Recent patents relating to making and using lipid coatings for the delivery of therapeutic agents.

Haplotype-resolved genome assemblies are generated by combining HiFi reads with Hi-C long-range interactions.

SARS-CoV-2 neutralizing antibodies are readily detected with a biosensor.

The bacterial life in glaciers is comprehensively catalogued and analyzed.

Analysis of spatial transcriptomics is improved by correlating cell-type compositions across tissue locations.

DestVI models continuous cell states in spatial transcriptomics data.

Influenza virus is attenuated for vaccine production using PROTAC degradation technology.

Continuously evolved double-stranded DNA deaminases increase the efficiency and targeting scope of all-protein base editors.

A split prime editor simplifies delivery.

Prime editing in plants is improved fivefold through molecular engineering.

Rice yield is boosted by overcoming a trait tradeoff.

The sustainable protein sector, which promises to create a better food system for the planet, is part of a growing industry with a lot to offer to young researchers.

Recent moves of note in and around the biotech and pharma industries.